Medicare Enrolled
Dr. Erick Bournigal, MD
Rheumatology · Brunswick, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bournigal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bournigal?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bournigal
Dr. Erick Bournigal is a rheumatology specialist in Brunswick, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Bournigal performed 186,034 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Bournigal received a total of $19,698 from 50 pharmaceutical and/or device companies across 590 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bournigal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 5% volume in GA
$19,698 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗186,034
Medicare services
Top 5% in GA for rheumatology
Not available
Unique patients (not deduplicated)
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tocilizumab injection (Actemra) | 81,880 | $5 | $12 |
| Romosozumab injection (Evenity) for osteoporosis | 57,225 | $8 | $23 |
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
30,000 | $4 | $11 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
9,849 | $11 | $27 |
| Denosumab injection (Prolia/Xgeva) | 4,200 | $18 | $45 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
768 | $50 | $189 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
680 | $80 | $270 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
537 | $1 | $15 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
312 | $86 | $345 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
190 | $58 | $184 |
| New patient office visit, complex (60-74 min) | 133 | $149 | $521 |
| Joint fluid aspiration or injection, medium joint Removal of fluid from a medium-sized joint or injection of medication into the joint space. |
108 | $27 | $145 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
60 | $40 | $175 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
42 | $135 | $364 |
| Joint fluid aspiration or injection, small joint Removal of fluid from a small joint or injection of medication into a small joint. |
25 | $29 | $135 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
25 | $124 | $415 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
5.5% high complexity
94.0% medium
0.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$19,698
Total received (2018-2024)
Avg $2,814/year across 7 years
Top 16% in GA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
590
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,195
2023
$3,447
2022
$8,442
2021
$655
2020
$268
2019
$1,171
2018
$1,520
Payments by company (2024)
Janssen Biotech, Inc.
$1,012
ABBVIE INC.
$516
Mallinckrodt Hospital Products Inc.
$330
Amgen Inc.
$315
UCB, Inc.
$283
GENZYME CORPORATION
$275
PFIZER INC.
$274
Cardinal Health 110 LLC
$254
ANI Pharmaceuticals, Inc.
$182
AstraZeneca Pharmaceuticals LP
$159
Genentech USA, Inc.
$82
Radius Health, Inc.
$67
SANOFI-AVENTIS U.S. LLC
$55
Axsome Therapeutics, Inc.
$50
Actelion Pharmaceuticals US, Inc.
$44
Novartis Pharmaceuticals Corporation
$41
Kiniksa Pharmaceuticals International, plc
$40
Boehringer Ingelheim Pharmaceuticals, Inc.
$32
Takeda Pharmaceuticals U.S.A., Inc.
$27
GlaxoSmithKline, LLC.
$26
Organon Llc
$25
E.R. Squibb & Sons, L.L.C.
$24
Azurity Pharmaceuticals, Inc.
$23
Almatica Pharma LLC
$22
Lilly USA, LLC
$19
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$17
Top 3 companies account for 44.3% of 2024 payments
All-time payments by company (2018-2024) ›
Horizon Therapeutics plc
$6,155
Janssen Biotech, Inc.
$1,755
GENZYME CORPORATION
$1,371
Amgen Inc.
$1,343
ABBVIE INC.
$1,104
UCB, Inc.
$944
PFIZER INC.
$801
Mallinckrodt Hospital Products Inc.
$683
AbbVie Inc.
$610
AstraZeneca Pharmaceuticals LP
$589
Radius Health, Inc.
$504
GlaxoSmithKline, LLC.
$394
ANI Pharmaceuticals, Inc.
$331
AbbVie, Inc.
$316
Genentech USA, Inc.
$286
Cardinal Health 110 LLC
$254
Lilly USA, LLC
$229
Boehringer Ingelheim Pharmaceuticals, Inc.
$210
Aurinia Pharma U.S., Inc.
$203
SANOFI-AVENTIS U.S. LLC
$195
Novartis Pharmaceuticals Corporation
$175
Takeda Pharmaceuticals U.S.A., Inc.
$152
Horizon Pharma plc
$136
DePuy Synthes Sales Inc.
$92
Organon LLC
$91
Axsome Therapeutics, Inc.
$72
Mallinckrodt LLC
$68
Almatica Pharma LLC
$66
Azurity Pharmaceuticals, Inc.
$57
Actelion Pharmaceuticals US, Inc.
$56
Celgene Corporation
$46
E.R. Squibb & Sons, L.L.C.
$41
Kiniksa Pharmaceuticals International, plc
$40
Mallinckrodt Enterprises LLC
$38
Allergan Inc.
$30
ARBOR PHARMACEUTICALS, INC.
$27
Organon Llc
$25
Kiniksa Pharmaceuticals, Ltd.
$22
Merck Sharp & Dohme Corporation
$20
Grifols USA, LLC
$19
Ironwood Pharmaceuticals, Inc
$17
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$17
Fresenius Kabi USA, LLC
$15
Biohaven Pharmaceutical Holding Company Ltd.
$15
BOSTON SCIENTIFIC CORPORATION
$15
Novo Nordisk Inc
$14
Boston Scientific Corporation
$14
Nalpropion Pharmaceuticals LLC
$14
CSL Behring
$13
Bioventus LLC
$13
Top 3 companies account for 47.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Actemra · Arcalyst · Auvelity · BENLYSTA · Bimzelx · CAPLYTA · COMIRNATY · CONTRAVE · COSENTYX · Cimzia · DUZALLO · Durolane · EVENITY · Enbrel · FORTEO · GENERAL PAIN MANAGEMENT · GRALISE · HADLIMA · HORIZANT · HUMIRA · HYQVIA · Hizentra · Horizant · Humira · INFLECTRA · KEVZARA · KRYSTEXXA · LUPKYNIS · MONOVISC · NURTEC ODT · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · ORENCIA · Otezla · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · Saxenda · TALTZ · TAVNEOS · TERIPARATIDE · TEZSPIRE · TREMFYA · TRINTELLIX · Trintellix · Tymlos · Uloric · VRAYLAR · WAVEWRITER ALPHA · XELJANZ · Xembify
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
2
County median income
$68,546
Nearest hospital to ZIP centroid (approximate)
SOUTHEAST GEORGIA HEALTH SYSTEM- BRUNSWICK CAMPUS
10.1 mi
10.1 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bournigal is a mixed practice specialist, with above-average Medicare volume (top 5% in GA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bournigal experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Bournigal performed 81,880 tocilizumab injection (actemra) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Bournigal receive payments from pharmaceutical companies?
Yes. Dr. Bournigal received a total of $19,698 from 50 companies across 590 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bournigal's costs compare to other rheumatologists in Brunswick?
Dr. Bournigal's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bournigal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Brunswick
Browse rheumatologists in Brunswick ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in GA
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in GA
Which GA rheumatologists receive the most from drug and device companies.
By company
Horizon Therapeutics plc Payments to Doctors
See all physicians who received payments from Horizon Therapeutics plc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology